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RESEARCH ARTICLE Open Access
Octo- and nonagenarians’ outlook on life
and death when living with an implantable
cardioverter defibrillator: a cross-sectional
study
Ingela Thylén1*, Debra K. Moser2 and Anna Strömberg1,3
Abstract
Background: Elderly individuals are increasingly represented among patients with implantable cardioverter
defibrillators (ICD), but data describing life with an ICD are scarse among octo- and nonagenarians. Moreover, few
studies have reported those elderly patients’ perspective on timly discussions concerning what shock deactivation
involves, preferences on battery replacement, and their attitudes about turning off the ICD nearing end-of-life.
Consequently, the aim of the study was to describe outlooks on life and death in octo- and nonagenarian ICD-
recipients.
Methods: Participants were identified via the Swedish Pacemaker- and ICD-registry, with 229 octo- and
nonagenarians (82.0 ± 2.2 years, 12% female) completing the survey on one occasion. The survey involved questions
on health and psychological measures, as well as on experiences, attitudes and knowledge of end-of-life issues in
relation to the ICD.
Results: The majority (53%) reported their existing health as being good/very good and rated their health status as
67 ± 18 on the EuroQol Visual Analog Scale. A total of 34% had experienced shock(s), 11% suffered from symptoms
of depression, 15% had anxiety, and 26% reported concerns related to their ICD. About one third (34%) had
discussed their illness trajectory with their physician, with those octo- and nonagenarians being more decisive
about a future deactivation (67% vs. 43%, p < .01). A minority (13%) had discussed what turning off shocks would
involve with their physician, and just 7% had told their family their wishes about a possible deactivation in the
future. The majority desired battery replacement even if they had reached a very advanced age when one was
needed (69%), or were seriously ill with a life-threatening disease (55%). When asked about deactivation in an
anticipated terminal illness, about one third (34%) stated that they wanted to keep the shocks in the ICD during
these circumstances. About one-fourth of the octo- and nonagenarians had insufficient knowledge regarding
the ethical aspects, function of the ICD, and practical consequences of withdrawing the ICD treatment in the
end-of-life.
Conclusions: Increasing numbers of elderly persons receive an ICD and geriatric care must involve assessments of
life expectancy as well as the patient’s knowledge and attitudes in relation to generator changes and deactivation.
Keywords: Attitudes, Deactivation, End-of-life, Implantable cardioverter defibrillator, Knowledge, Nonagenarians,
Octogenarians, Psychosocial distress, Quality-of-life, Shock
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Background
For over 20 years, implantable cardioverter defibrillators
(ICDs) have been the treatment of choice for individuals
at risk for - or with a history of - sudden cardiac death at-
tributable to ventricular arrhythmias [1]. When ICDs are
combined with cardiac resynchronisation therapy (CRT)
in heart failure patients, symptom burden and survival are
improved [1]. Therefore today, elderly individuals are in-
creasingly represented among patients with ICDs and
studies have shown that > 40% of ICDs and CRT devices
are inserted in individuals ≥ 70 years of age [2]. About
12% of those deemed eligible for ICD implantation by
conventional criteria are ≥ 80 years of age (i.e., octogenar-
ians) [2]. Although guidelines state that ICD implantation
is “rarely appropriate” in nonagenarians (i.e., ≥ 90 years of
age) [3], they do not refer to any specific age limits, but ra-
ther to 1-year life expectancy as a mandatory criterion.
As the population ages, many are at greater risk of de-
veloping progressive multimorbidity, and therefore are
likely to die of causes other than sudden cardiac death [4].
Under these circumstances, shocks may only cause a pro-
longation of the dying process [5]. During the first years
after implantation, the risks of receiving at least one ICD
shock can range from one third in primary preventive pa-
tients [6, 7] to up to 50% in patients with a secondary indi-
cation [8]. Even among those without shocks during the
ICD’s first battery life, the incidence of shocks at 5 years
following generator exchange is > 25% [6] which can nega-
tively affect quality-of-life (QOL) [9]. A recent systematic
review that assessed > 5000 ICD-recipients reported that
approximately 20% have clinically significant psychological
distress with anxiety and/or depression the first year(s)
post-implantation [10]. Furthermore, 31% receive a
shock(s) in the last 24 h of their lives, decreasing their
quality-of-death [5].
An ICD deactivation should be considered when a
patient’s clinical status worsens and death is near. De-
activating an ICD can be achieved in the following
ways, which are ethically and legally equivalent: planned
ICD deactivation through reprogramming, urgent tempor-
ary ICD deactivation using a magnet which temporarily
stops the ICD delivering shocks whilst in position over the
ICD, or not replacing the ICD when the device has
reached the end-of-service indicator [11].
Effective communication between clinician and pa-
tient includes determining the patients’ goals of care,
helping patients to weigh the benefits and burdens of
device therapy as their clinical situation changes, clarifying
the consequences of deactivation, and discussing potential
alternative treatments [12]. Therefore, in order to improve
QOL for patients at the end of their lives, and to provide
direction for clinicians, it is adviced that clinicians raise
the question about elective ICD deactivation before im-
plantation of the device and then recurrently during the
illness trajectory [11, 13], yet few patients or families dis-
cuss the option of device deactivation with their physi-
cians [14]. Many do not know that device deactivation is
an available option, [15] which may result in a potentially
painful end-of-life situation with the ICD not being deacti-
vated [16]. There are several obstacles to effective commu-
nication and patient education regarding this issue. Firstly,
many professionals still feel uncomfortable discussing
end-of-life with their patients [17] and lack the compe-
tence and skills to communicate about end-of life issues
[18, 19]. Secondly, professionals may feel uncertain about
if and/or when patients prefer to discuss generator re-
placement and deactivation, which could result in a de-
layed end-of-life discussion [20]. Thirdly, patients might
not want to discuss this topic at all [14, 21, 22].
Despite the increasingly high rate of ICD implantation
in elderly patients, data describing their life-situation,
experiences and perspectives on the timing of ICD de-
activation discussions, and preferences on deactivation
as the patient nears end-of-life, are scarse. Therefore, the
overall purpose of this study was to describe outlook on
life and death in octo- and nonagenarian ICD-recipients.
The specific aims are as follows, using a cross-sectional
design: 1) to describe self-rated perceived health and
psychological distress; and 2) to describe experiences, at-
titudes and knowledge of end-of-life issues.
Methods
In 2012, we used the Swedish ICD- and Pacemaker
registry to identify and invite all eligible ICD- and
CRT-D (cardiac resynchronization therapy with defibril-
lator) recipients (n = 5535) at the time to complete stan-
dardized self-reported questionnaires, on one occasion.
The survey involved questions on health and psycho-
logical measures, as well as on experiences, attitudes and
knowledge of end-of-life issues in relation the the ICD/
CRT-D. The inclusion criteria were being eligible for the
registry (i.e., having a valid postal mail address), being
≥ 18 years old, having had the device for at least 1
year, and willingness to participate. The study was approved
by the Regional Ethics Committee for Human Research at
the University of Linköping, Sweden (Dnr 2011/434–31).
The results from the main study are reported elsewhere
[14, 23–25]. In this sub-study we have analysed data from
those ≥ 80 years old.
Measures
Demographic and clinical data
Demographic data, co-morbidity and previous shock
experience were obtained through purpose-designed
questions whereas clinical variables such as primary vs.
secondary indication and time since implantation were
obtained from the Swedish ICD- and Pacemaker registry.
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Quality-of-life and psychological measures
Quality-of-life was measured using the EuroQol-5D
(EQ-5D) [26], an instrument with well-established reliabil-
ity and validity. Symptoms of anxiety and depression was
measured using the Hospital Anxiety and Depression Scale
(HADS) [27], which has been used extensively in both
hospitalized and non-hospitalized patients. The literaure
supports the use of ≥8 as a cut-off, as it yields an optimal
balance between sensitivity and specificity for the presence
of symptoms of anxiety and depressive symptoms [28].
ICD-related concerns was measured using the 8-item Pa-
tient ICD Concerns (ICDC) questionnaire, which is a brief
instrument that can be used to identify patients at risk for
adverse outcomes in clinical practice. [29]. As there is no
standardized cut-off for the ICDC, the instrument con-
structors [30] suggest dividing patients into a high vs. low
concern group, using the highest tertile in the sample to
indicate a high level of concerns. Perceived social support
from family, friends, and significant others was mea-
sured using the Multidimensional Scale of Perceived
Social Support (MSPSS) [31]. The higher total score,
the higher the perceived social support. In addition,
separate subscales can be used by summing the re-
sponses from the items in each of the three dimensions.
The 4-item, Control Attitudes Scale (CAS) was used to
measure perceived control [32]. Higher scores indicate
greater perceptions of control. As recommended from
the literature, we used the median in the sample as a
cut-off for low vs. high perceived control [33].
End-of-life concerns
Data on experiences, attitudes and knowledge of
end-of-life concerns was measured using the EOL-ICD
Questionnaire [34]. The EOL-ICDQ is a self-rated
questionnaire containing three domains that measure
experiences (10 items), attitudes (18 items) and knowledge
(11 items) of end-of-life in ICD-recipients. Participants list
their answer as “yes/no” or “no opinion”, “agree/don’t
agree”, “true/false”, or “don’t know”. The experiences
domain includes items about patients’ actual discussion
experiences. Example items in this domain are “I have dis-
cussed what a battery replacement involves with my ICD
doctor or nurse”, and “I have told my next of kin (either in
writing or orally) my wishes regarding the shocks in my
ICD, if I become seriously ill with some fatal disease”. The
attitudes domain includes items about patients’ attitudes
towards potential future discussions and future events. Ex-
amples of items are “I want to have the battery in my ICD
replaced even if I am seriously ill suffering from another
disease” and “I want to have the shocks in my ICD even if
dying of cancer or another serious disease”. The know-
ledge domain involves 3 statements on ethical aspects, 2
statements on the fuction of the ICD, and 6 statements on
practical consequences associated with ICD deactivation,
such as “Deactivating the shocks is the same as active eu-
thanasia” (i.e., false) and “When the shocks are turned off,
the heart stops beating” (i.e., false).
Statistical analysis
All analyses were conducted using SPSS software, version
22 (SPSS, Chicago, Illinois). We used frequencies and pro-
portions to describe the sample, their self-rated perceived
health and psychological distress, as well as their experi-
ences, attitudes and knowledge of end-of-life issues.
Mann-Withney U-tests and chi-square tests were used to
determine bivariate associations of socio-demographic,
clinical, and psychological measures with positive and
negative outlook on life and death (i.e., self-rated per-
ceived health, willingness to discuss deactivation, attitudes
on elective generator replacement at end-of-service indi-
cator, and attitudes about maintaining ICD therapy in the
context of terminal illness). As recommended in the litera-
ture [16], the 25th percentile in the sample (i.e., ≤3) was
used as a cut-off for insufficient knowledge in the
knowledge domain in the EOL-ICDQ. Probability values
of p < .05 were considered significant.
Results
Background characteristics
Of the 5535 patients who were mailed the survey, 12%
were > 80 years of age. A total of 3067 patients com-
pleted the survey, covering 55% of all Swedish
ICD-recipients at the time for the study. Of these, 229
(7,5%) were octo- and nonagenarians and included in
this analysis. The mean age of this sub-sample was 82.0
± 2.2 years with a range of 80 to 94 years, with the ma-
jority being male (88%). Time since implantation ranged
from one to 23 years with a mean of 5.5 ± 4.2 years, 25%
had a CRT-D implanted and 32% had previously under-
gone an elective battery replacement. The majority
(72%) had received their ICD as secondary prevention
treatment, while the remainder had received their ICD
for primary prevention, usually in the context of heart
failure. The number of co-morbid conditions in total
varied from 0 to 11, with 57% of the patients having ≥3
co-morbid conditions (mean 3.1 ± 1.9) (Table 1).
Outlook on life
The vast majority rated their general experiences as
ICD-recipients as “good” or “very good” (97%). The cor-
responding percentage for their perceived general health
experience was 53%, with a EuroQol VAS score ranging
from 10 to 100 (67 ± 18) and a mean index of 0.783.
The lowest proportion of reported health problems was
seen in the self-care dimension (8%) whereas the highest
proportion of problems were seen in the mobility di-
mension (52%) (Fig. 1). A worse health condition (i.e.,
EQ-VAS) was described by patients with a history of
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myocardial infarction (64 vs. 70, p < .05), heart failure
(64 vs. 71, p < .01), kidney disease (57 vs. 69, p < .01), or
intermittent claudiocation (60 vs. 69, p < .001) compared
to their counterparts. Also patients with symptoms of
depression and anxiety, and ICD-related concerns re-
ported a worse health condition (EQ-VAS 44 vs. 70, 47
vs. 71 and 61 vs. 70, respectively, p < .000).
In total, 11% reported symptoms of depression, 15%
anxiety, 26% had ICD-related concerns, and 32% de-
scribed a low perceived control in life (Table 2). Those
with symptoms of anxiety also perceived a lower con-
trol compared to them without anxiety (52% vs. 28%,
respectively, p < .01). This was also true for the patients
with high ICD-related concerns; 45% described a low
control in this group compared to 26% in the group
without any concerns (p < .01).
About one third of the patients (34%) had received at
least one shock and that experience was also correlated
with a higher percentage of symptoms of anxiety com-
pared to those without any shock experience in the past
(24% vs. 10%, respectively, p < .01). In connection with the
latest shock, they rated their pain and their anxiety experi-
ence as 4.1 and 3.6 on a 10 point numeric rating scale, re-
spectively. The ICD-recipients were least concerned about
not being able to prevent the ICD from firing, with 46%
being concerned for this reason. ICD-recipients were most
concerned that working too hard/overdoing things might
cause the ICD to fire, with 65% sharing this concern
(Fig. 2). A minority (27%) stated that they had a religious
faith or outlook on life helping them in their daily life as
an ICD-recipient.
Outlook on death
Nearly one forth (24%) of the octo- and nonagenarians
stated that they often thought about death, and one third
(34%) had discussed their illness trajectory with their
physician. About 40% had at some time discussed what
a forthcoming generator replacement would involve for
them, and 30% had discussed the topic with a family
member. The vast majority (87%) had not discussed with
their physician about what turning off the shocks would
involve if their health deteriorates, and just 7% had told
Table 1 Background characteristics, N = 229
Characteristica Valueb
Demographics
Age (years) 82.0 (2.2)
Gender (male) 201 (87.8%)
Education (lower)c 102 (44.5%)
Living alone (yes) 55 (24.3%)
Clinical factors
Time since implantation (years) 5.5 (4.2%)
ICD-indication (primary prevention) 65 (28.4%)
Resynchronization therapy (CRT-D, yes) 57 (24.9%)
Shock experience (yes) 76 (33.9%)
Generator replacement (yes) 73 (31.9%)
Co-morbidity
Myocardial infarction 92 (40.2%)
Atrial fibrillation 125 (54.6%)
Heart failure 131 (57.2%)
Chronic obstructive pulmonary disease 32 (14.0%)
Diabetes mellitus 33 (14.4%)
Stroke 27 (11.8%)
Cancer 29 (12.7%)
aSelf-reported by subjects
bData are presented as mean (SD) or n (%)
cCompulsory secondary school, with a total education time ≤ 9 years
Fig. 1 ICD-recipients perceived health, measured with EQ-5D
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their family their stance about deactivation when near-
ing end-of-life. Among those who had discussed their
wishes, 93% perceived a high control in life compared
to 65% among those that had not discussed this issue
with their family (p < .05). Six participants had consid-
ered deactivation in the future. Many of the partici-
pants (40%) stated that they under no circumstances
wanted to discuss deactivation. Among those who
wanted to discuss deactivation, 51% found it appropri-
ate to have the discussion at implantation, while 61%
wanted to discuss deactivation if suffering from a poor
prognosis, and 67% towards the end-of-life (Fig. 3).
When being faced with three different scenarios at
the time for the end-of-service indicator in the ICD,
most of the participants stated that they would like to
replace the ICD even if no shock therapy had been de-
livered (76%), if had reached a very advanced age (69%),
or if being seriously ill in a life-threatening disease at
that time (55%). When asked about deactivation in an
anticipated terminal illness, about one third of patients
(34%) stated that they wanted to keep the shocks in the
ICD during these circumstances, and 15% wanted to
keep the shocks even if having shocks daily (Fig. 4).
Those with a CRT-D implanted were more able to take
a stand about deactivation (yes or no) if falling ill in a
terminal illness compared to those without a CRT-D
(77% vs. 62%, respectively, p < .05). This was also true
for participants with a history of myocardial infarction
when compared to their counterparts (76% vs. 60%,
respectively, p < .01). Furthermore, those who had
discussed deactivation with their family were more able
to take a stand about deactivation in an anticipated
Table 2 Psychological characteristics, N = 229
Characteristica Valueb
Perceived ICD experience
Experiences of the ICD-treatment (“good/very good”) 213 (96.8%)
Pain experience with the latest shock,
numeric rating scale (score 0–10)
4.1 (3.2)
Anxiety experience with the latest shock,
numeric rating scale (score 0–10)
3.6 (2.9)
Quality-of-life (EQ-5D)
Quality-of-life index, mean 783 (.212)
Quality-of-life, visual analogue scale,
total (score 0–100)
67.4 (18.4)
Poor quality-of-life, visual analogue
scale, 0–65
71 (34.1%)
Moderate quality-of-life, visual analogue
scale, 66–79
74 (35.6%)
Good quality-of-life, visual analogue
scale, 80–100
63 (30.3%)
Psychological distress
Symptoms of anxiety (HADS-A) 32 (14.6%)
Symptoms of depression (HADS-D) 25 (11.2%)
ICD-related concerns (ICDC) 57 (26.1%)
Low perceived control (CAS) 71 (32.0%)
Percieved social support (MSPSS), (score 12–84) 71.4 (15.1)
aSelf-reported by subjects
bData are presented as mean (SD) or n (%)
Fig. 2 ICD-related concerns, measured with ICD-C. 1) My ICD firing; 2) Doing activities/hobbies that may cause my ICD to fire; 3) Time spent
thinking about my ICD firing; 4) Working too hard/overdoing things causing my ICD to fire; 5) Having no warning my ICD will fire; 6) The
symptoms/pain associated with my ICD firing; 7) Not being able to prevent my ICD from firing; 8) Getting too stressed in case my ICD fires
Thylén et al. BMC Geriatrics          (2018) 18:250 Page 5 of 9
terminal illness (86% vs. 65%, respectively, p < .05). When
it came to an anticipated situation with daily shocks, again
those with a history of myocardial infarction were more
able to take a stand (yes or no) about deactivation com-
pared to those without myocardial infarction (60% vs.
45%, respectively, p < .05). Those who hade discussed their
illness trajectory with their physician were also more
decisive about this situation with 67% being able to take a
stand about deactivation compared to 43% among those
who had not discussed their illness trajectory with their
physician, p < .01. Finally, those who were willing to
discuss deactivation with their physician had less often
had a battery replacement (44% vs. 66%, p < .01), more
often a history of atrial fibrillation (68% vs. 49%, p < .01) or
Fig. 3 Octo-nonagenarians preferences about the timing to discuss what deactivation involves
Fig. 4 Octo-nonagenarians preferences about if to replace the ICD battery when it has reached the end-of-service indicator given three different
scenarios, and if keep shocks in an anticipated future with worsening of the health
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diabetes (75% vs. 57%, p < .05). There were no other sig-
nificant differences in the bivariate analyses between
different socio-demographic, clinical, or psychological
measures and those who were willing to discuss deacti-
vation of the ICD, or were able to take a stand about
deactivation (yes or no) or were indecisive about their
standpoint in case of terminal illness or having shocks
daily.
Only two participants (1%) recieved the highest pos-
sible points on the knowledge questionnaire, whereas
17 participants (8%) did not know or scored incorrectly
on all statements. The mean score in the sample was
5.6 ± 3.0 out of 11 possible scores, with 54 participants
(26%) having insufficient knowledge. In the ethical do-
main, the statement “When an ICD’s defibrillating
shocks are turned off, the heart stops beating,” (i.e.,
false) resulted in the highest score with 74% responding
correctly. Approximately one third (36%) in-correctly
believed that deactivation was the same as active eu-
thanasia. The two statements in the domain covering
the function of the ICD, i.e., “When the battery voltage
is beginning to wear, the ICD’s functioning worsens”
and “When the shocks are turned off, the pacemaker
function in the ICD is also turned off,” were correctly
responded to as false by 23% and 30%, respectively. In
the last domain about practical consequences of draw-
ing the ICD treatment at the end-of-life, only 24%
scored correct (i.e., false) to the statement “An ICD al-
ways delivers defibrillating shocks in connection with
end-of-life”. Additionally, approximately one third of
the octo- and nonagenarians (37%) incorrectly believed
that the ICD must be removed by surgery in order to
be turned off, and 44% believed that when the ICD has
been deactivated, it cannot be activated again.
Discussion
Our study, conducted in a national sample of octo- and
nonagenarian ICD-recipients, demonstrated that nearly
one-third of the participants experienced a good QOL and
their overall ICD experience was considered good or very
good in almost all the participants. Further, they reported
similar prevalence of symptoms of anxiety and depression
as in a Swedish norm population in this age group [35].
As many as 26% had ICD-related concerns and were most
concerned about that working too hard/overdoing things
may cause the ICD to fire. This is noteworthy since fear
may influence and decrease activity levels in daily life
[36, 37] which in turn has been found to strongly correl-
ate with survival following ICD-implantation [38].
We found that only a minority had discussed the impli-
cations of generator replacement at battery-end-of-service
or had discussed potential ICD deactivation at the
end-of-life. Moreover, many participants were unable to
foresee what they might prefer to do with their ICD in an
end-of-life situation. Two thirds of the participants in our
study wanted to replace their battery irrespectable of
age and half of them wanted this done also when being
seriously ill. As many as one third required to keep the
ICD active until they died. These findings suggest that
many patients with an ICD are at risk of not dying
peacefully, painlessly and with dignity. It is the reality
that many dying ICD-recipients receive shocks in their
last days of life. A recent Swedish study by Westerdahl et
al. showed that one out of four patients received at least
one shock during the last day of their life. It is noteworthy
that this study also showed that ICD devices were active in
half of patients with a do-not-resuscitate order [19].
Earlier studies have shown that patients and their
family members - as well as healthcare professionals -
are reluctant to speak about not replacing the battery
or deactivation [17, 21, 39]. Our study underlines
these findings and showed that remarkably few had
discussed deactivation with their physician and/or
family members. A study by van der Wal et al. found
that many elderly and severly ill cardiac patients do
not know what to expect for the future and some have
unrealistic exectations on their long-term survival
[40]. Older people obviously have a higher annual rate
of death – with a 38% mortality rate 2 years after ICD
replacement in octogenarians reported in a recent
study [41], and this fact must be taken into consideration
when discussing future expectations with the patient. Our
study further showed that about one-forth of the partici-
pants had insufficient knowledge regarding the ethical as-
pects, function of the ICD, and practical consequences of
withdrawing the ICD treatment in the end-of-life. We
have previously shown that increased knowledge improve
the compentences and skills of making a decision, in
favour of deactivation or not [16]. Dodson et al., [42]
found that providing information regarding the best
current evidence on benefits and burdens of an ICD with
focus on person-centered outcomes, triggered that
ICD-recipients made a decision for deactivation in at least
1 out of 5 end-of-life scenarios [42]. However, the lack of
knowledge is not just on the patient side. Many physi-
cians, medically responsible for elderly patients with an
ICD, have limited knowledge of ICD treatment and may
therefore not be able to provide the best possible care
from implantation to the end-of-life in the elderly
ICD-recipients [19]. Thus, we see a need for more educa-
tion on ICD care and communication about deactivation
to physicians both in geriatrics, internal medicine and pri-
mary care as well as a more close collaboration with cardi-
ologists and device nurses responsible for ICD follow-up.
Methodological issues
The study has several limitations with the design being
cross sectional and data collected by self-report. Only
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one data collection point was used, therefore it is not
known if the individual’s psychological distress existed
before the ICD-implantation. A longitudinal study of a
large cohort of older ICD-recipients would be helpful in
understanding the process of adjustment, changes in
psychological distress and outlook on death over time.
Even thought this is a national registry based study, we
may have had a selection bias with those octo- and
nonagenarian ICD-recipients responding to the survey
being less burdened by psychosocial distress and having
better QOL. However, a reasonable response rate and a
large sample size contributed strength to the results.
Lastly, more than 60% of participants had ICD im-
planted as secondary prevention. This is a relatively high
rate for current practice which could be seen as a limita-
tion, but could be explained by the rather long time
since implantation ranging up to 23 years.
Conclusions
We found that most octo- and nonagenarian ICD-re-
cipients report a good health with similar prevalence of
psychological distress as younger ICD-recipients and
other populations in the same age group. They view
their ICD experience as positive and continue to desire
ICD therapy in spite of age or serious illness. However,
a significant majority of patients have not discussed
possible future deactivation with their physician or
family. Misunderstandings regarding withdrawing the
ICD treatment in the end-of-life were evident, which
may result in a potentially painful end-of-death with
the ICD not being deactivated. Increasing numbers of
elderly persons receive an ICD and geriatric care must
remember involving assessments of life expectancy as
well as the patients’ knowledge and attitudes in relation
to generator changes and deactivation. These conversa-
tions should continue over the course of the patient’s
lifespan, since patient preferences may change as illness
progresses and deactivation needs to be a deliberate de-
cision based on knowledge.
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